Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China
Ji Hongxiang, Sun Hualin, Zhang Yinghui, Zhao Ziyi, Gao Xin, Wang Chunhe, Yang Yang, Zhang Xiaodong, Gao Jianyong, Man Dequan, Yang Qian, Yang Ying, Yue Chengbin, Chen Changjiang, Ding Xiaoheng, Ni Tongshang · Frontiers in Cardiovascular Medicine · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China” is organized in H2HUBB under the research focus hydrogen inhalation blood pressure study 2024. The publication is cited as Ji Hongxiang, Sun Hualin, Zhang Yinghui, Zhao Ziyi, Gao Xin, Wang Chunhe, Yang Yang, Zhang Xiaodong, Gao Jianyong, Man Dequan, Yang Qian, Yang Ying, Yue Chengbin, Chen Changjiang, Ding Xiaoheng, Ni Tongshang, Frontiers in Cardiovascular Medicine, 2024. This observational study examined Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China. The abstract describes Human participants; hydrogen delivered as hydrogen inhalation; reported duration 24 week. The abstract reports: The HI therapy is related to significant amelioration in BP levels with acceptable safety profile in Chinese hypertensive adults after 24 weeks of treatment,…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation blood pressure study 2024 overview
To evaluate the real-life effectiveness and safety of hydrogen inhalation (HI) therapy as an additional treatment in Chinese adults with hypertension. Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Observational study. Evidence type: Human clinical evidence. Research model or population: Human participants. Blinding: Unknown. Control status: Control group reported.
Delivery method: Hydrogen inhalation. Treatment duration: 24 week.
Reported findings and scientific interpretation
For this hydrogen inhalation blood pressure study 2024, the study record reports the following: The abstract reports: The HI therapy is related to significant amelioration in BP levels with acceptable safety profile in Chinese hypertensive adults after 24 weeks of treatment,…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The HI therapy is related to significant amelioration in BP levels with acceptable safety profile in Chinese hypertensive adults after 24 weeks of treatment,…
Safety: To evaluate the real-life effectiveness and safety of hydrogen inhalation (HI) therapy as an additional treatment in Chinese adults with hypertension.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.